Opus Genetics Inc Share Price Today: Live Updates & Key Insights
Opus Genetics Inc share price today is $4.47, up -4.15%. The stock opened at $4.5 against the previous close of $4.58, with an intraday high of $4.67 and low of $4.35.
Opus Genetics Inc Share Price Chart
Opus Genetics Inc
Opus Genetics Inc Share Price Performance
Opus Genetics Inc Institutional Holdings
Opus Genetics Inc Market Status
Opus Genetics Inc Fundamentals
Market Cap 312.34 M
PB Ratio 21.2316
PE Ratio 0.0
Enterprise Value 281.90 M
Total Assets 50.24 M
Volume 847023
Opus Genetics Inc Company Financials
About Opus Genetics Inc & investment objective
Company Information Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. It develops OPGx-LCA5, an early-onset retinal degeneration that is in Phase 1/2 clinical trial for the treatment of LCA5-associated IRD; and OPGx-BEST1 to treat BEST1-associated retinal disease. The company also develops various pre-clinical IRD programs, including OPGx-RHO, a gene therapy that targets autosomal dominant retinitis pigmentosa caused by RHO mutations; OPGx-RDH12 that is designed to restore protein expression and halt functional deterioration in patients with retinal dystrophy caused by mutations in the retinal dehydrogenase gene; OPGx-MERTK, an AAV vector for the treatment of MERTK IRD; OPGx-NMNAT1, a gene augmentation therapy designed to halt functional deterioration in pediatric patients with retinal degenerative disease caused by mutations in the nicotinamide mononucleotide adenylyltransferase 1 gene; and OPGx-CNGB1, an AAV gene therapy for retinitis pigmentosa due to mutations in the CNGB1 gene. In addition, it develops Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as for the treatment of presbyopia and dim light or night vision disturbances and APX3330, a small-molecule inhibitor of Ref-1 for the treatment of diabetic retinopathy. Opus Genetics, Inc. was formerly known as Ocuphire Pharma, Inc. and changed its name to Opus Genetics, Inc. in November 2020. The company was founded in 2018 and is headquartered in Durham, North Carolina.
Organisation Biotechnology
Employees 27
Industry Biotechnology
CEO Mr. George Magrath M.B.A., M.D., M.S.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Opus Genetics Inc FAQs
What is the share price of Opus Genetics Inc today?
The current share price of Opus Genetics Inc is $4.47.
Can I buy Opus Genetics Inc shares in India?
Yes, Indian investors can buy Opus Genetics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Opus Genetics Inc shares in India?
You can easily invest in Opus Genetics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Opus Genetics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Opus Genetics Inc.
Can I buy fractional shares of Opus Genetics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Opus Genetics Inc?
Opus Genetics Inc has a market cap of $312.34 M.
In which sector does Opus Genetics Inc belong?
Opus Genetics Inc operates in the Biotechnology sector.
What documents are required to invest in Opus Genetics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Opus Genetics Inc?
The PE ratio of Opus Genetics Inc is N/A and the PB ratio is 21.23.